Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-11-14 to 2023-11-15
Current total value of award: $5105.19
Description: 4562813722!QUILLIVANT XR ORAL SUSP 180ML 5MG/ML